MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.

Biotecnología

Mr. Lih-Ming  Tam

Interim Chief Financial Officer & Senior Controller

Dr. Wilfred A. Jefferies

Co-Founder, Chairman & Chief Science Officer

Dr. Lyle  Oberg M.D.

Co-Founder, Chief Executive Officer & Director

Chief Financial Officer & Senior Controller

Dr. Chaahat S.B Singh

Senior Operations & Research Mang.

Mr. Luke  Warkentin

Vice President of Corporation Devel.

Dr. Iryna  Saranchova Ph.D.

Chief Clinical Officer

Nombre	Capitalización
hVIVO plc	0M
VistaGen Therapeutics, Inc.	0M
BioVaxys Technology Corp.	0M
MedMira Inc.	0M
Regenicin, Inc.	0M
Vascular Biogenics Ltd.	0M
CorMedix Inc.	0M
Wave Life Sciences Ltd.	0M
Immuron Limited	0M
Aptevo Therapeutics Inc.	0M

MYND Life Sciences Inc.

MYND Life Sciences Inc. Lista de competidores

Principales competidores